RECURSION PHARMACEUTICALS-A
RXRXNASDAQ🏆 #1948 by market capEarnings Nov 4US Equity
$3.29▼ $0.06 (−1.84%)
Live1h▲ 0.1%
24h▼ 1.8%
7d▲ 3.4%
14d▲ 11.1%
30d▼ 0.3%
1y▼ 39.3%
🏦Market Cap
$1.73B
Small Cap
📈Revenue Growth (YoY)
+26.9%
High Growth
📊Gross Margin
-46.7%
Thin
💵FCF Margin
-790.5%
Thin
⚖️P/S Ratio
32.0x
Expensive
Otter Score
60
Fair
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-0.25
Expected
-0.24
miss
−4.20%
YoY +39.00%
Revenue
Actual
$7.30M
Expected
$10.97M
miss
−33.40%
YoY −61.80%
Consensus estimates
Recent quarters
Q3 2026
-0.25
miss
Q2 2026
-0.22
beat
Q1 2026
-0.21
beat
Q4 2025
-0.36
beat